MedPath

MARPE Effect With/Without MOP in Non-growing Patients

Not Applicable
Completed
Conditions
Maxillary Transverse Deficiency
Interventions
Procedure: MARPE without MOP
Procedure: MARPE with MOP
Registration Number
NCT06502041
Lead Sponsor
Mansoura University
Brief Summary

This study compares the effect of MARPE (mini-implant assisted rapid palatal expansion) versus MARPE+ MOP (Micro-osteo-perforation) on nasal airway and maxillary transverse deficiency in non-growing patients.

Detailed Description

All participants with skeletal transverse deficiency with unilateral or bilateral cross-bite aging 20-25 years were treated by expansion of maxillary arch as a first phase of treatment with one expander screw which was anchored to mini-implants placed in the palatal region (Mini-implant assissted rapid palatal expansion; MARPE). The patient's bone support in the anterior area of the palate was examined on CBCT. Micro-osteoperforation (MOP) was done along of medial palatine raphe in the intervention group. Control-group is the same of the intervention group but without micro-osteo-perforations.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  1. The age ranges from 20-25 years.
  2. Post pubertal adolescent
  3. Skeletal transverse deficiency with unilateral or bilateral cross-bite
  4. Extraction is not indicated in the lower arch.
  5. Upper permanent dentition is erupted up to the second molars.
  6. Average facial vertical growth pattern.
  7. Space deficiency in the upper arch is less than 8 mm
Read More
Exclusion Criteria
  1. Diseases and medications those are likely to affect bone biology.

  2. Evidence of root resorption.

  3. Poor oral hygiene.

  4. Previous orthodontic treatment.

  5. Evidence of bone loss.

  6. Active periodontal disease.

  7. Craniofacial congenital anomalies, such as cleft lip and palate.

  8. Pregnant females. 8. Presence of oral habits.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MARPE without MOPMARPE without MOP-
MARPE with MOPMARPE with MOP-
Primary Outcome Measures
NameTimeMethod
Stability of correction of transverse deficiencyabout 6 months

by measuring the same CBCT transverse reading and by superimposition of the scaneed models at the end of the research

Pain experience during activation of expander by visual analogue scale ( VAS)about 1 months

VAS: 0 ( no pain), 10 (unbearable pain)

Number of days till diastema appearanceabout 1 month

(days)

Amount of skeletal expansionabout 1 month

(mm)

Skeletal, Dental & Nasal readingsmeasured before treatment and after 6 month of treatment

from CBCT and scanned models measured in degrees \& mm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mansoura University

🇪🇬

Mansoura, Adakhlia, Egypt

© Copyright 2025. All Rights Reserved by MedPath